Arcturus Therapeutics Holdings Inc.

ARCTNASDAQHealthcare● Active

$7.12

$-0.18(-2.47%)

Market Cap$202372251

P/E Ratio—

52W High$24.17

52W Low$5.85

Avg Volume463K

Open$7.38

Beta2.35

Net Income Financials Revenue

Arcturus Therapeutics Holdings Inc. (ARCT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ARCT · net income · updated Jun 9, 2026

Core profitability metrics

ARCT · net income · margin · TTM · CAGR

Net income was −$65.8M for FY2025 (fiscal year ending 2025-12-31), up 18.7% year-over-year. Net profit margin was -97.9%. Based on available data, Arcturus Therapeutics Holdings Inc. has been profitable since at least 2022.

FY2025 Net Income−$65.8M▲ +18.7% YoY

Trailing 12M (TTM)−$78.7Mtrailing 4 quarters sum

Net Profit Margin-97.9%−$65.8M ÷ $67.2M

YoY Change+18.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2022

▸ FMP /income-statement · Annual · ARCT net income history · ARCT profit margin

Annual net income data

ARCT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$65.8M▲ +18.7%-97.9%$67.2M

FY2024Loss−$80.9M▼ 172.3%-58.5%$138.4M

FY2023Loss−$29.7M▼ 417.9%-18.8%$157.7M

FY2022★ First Profit$9.3M▲ +104.6%4.5%$205.8M

FY2021Loss−$203.7M▼ 182.3%-1648.0%$12.4M

Net income vs peers (Healthcare)

ARCT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Arcturus Therapeutics Holdings Inc.YOU

ARCT

−$65.8M+18.7%-97.9%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Arcturus Therapeutics Holdings Inc. (ARCT) reported net income of −$65.8M for FY2025 (fiscal year ending 2025-12-31), up 18.7% year-over-year. The net profit margin was -97.9% — meaning the company kept $-0.98 of every dollar of revenue as profit.

Based on available data, Arcturus Therapeutics Holdings Inc. has been profitable since at least 2022. Net income reached a peak of $9.3M in FY2022. Data available for 15 fiscal years.

Arcturus Therapeutics Holdings Inc.'s net profit margin was -97.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Arcturus Therapeutics Holdings Inc. net worth" — the company's market capitalization is a separate figure from ARCT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ARCT net income · 4 questions

Arcturus Therapeutics Holdings Inc. is not currently profitable on an annual basis. The company reported a net loss of $65.8M for FY2025.

is ARCT profitabledoes ARCT make a profitARCT profitabilityARCT profitable company

▸ Source: FMP /income-statement · GAAP · Arcturus Therapeutics Holdings Inc. · Arcturus Therapeutics Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026